The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He XL, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CA, Tozer DJ, Samson RS, Thomas DL, Du MQ, Luan SL, Michell AW, Altmann DR, Thompson AJ, Miller DH, Compston A, Chandran S.
Connick P, et al. Among authors: kolappan m.
Trials. 2011 Mar 2;12:62. doi: 10.1186/1745-6215-12-62.
Trials. 2011.
PMID: 21366911
Free PMC article.
Clinical Trial.